Three questions to Prof. Gottfried Baier
1. New immunotherapeutic drugs such as CAR-T cells can benefit patients with certain blood cancers such as leukemia, lymphoma and multiple myeloma. What are the main reasons that the use...
December 18, 2023
No Comments
Three questions to Romana Gugenberger, Chief Medical and Scientific Officer

1.   Despite novel immune-therapies against cancer there are still non-responders and relapses. Why is that? Romana Gugenberger:  Tumors are heterogeneous. Additionally, tumors are not static but evolve. Once a response…

January 28, 2022
No Comments